Personalis Inc (PSNL) Stock Analysis

Personalis Inc (PSNL) is a publicly traded company in the HEALTHCARE sector. It trades at $11.14, carries a market capitalization of $1.18B. This page summarizes the public market data, fundamentals, and frequently asked questions for PSNL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $11.14
• Market Cap: $1.18B
• EPS: $-1.02
• 52-Week High: $11.85
• 52-Week Low: $3.84

Market Sentiment

Personalis Inc currently has a Bullish sentiment score of 0.18.

About Personalis Inc

Personalis, Inc. is a pioneering leader in the cancer genomics field, offering advanced genomic sequencing and analysis that empowers personalized cancer therapies. Based in Menlo Park, California, the company utilizes its proprietary technology platform to generate high-quality genomic data, enhancing precision medicine initiatives and supporting healthcare professionals in making informed treatment decisions. With a robust and expanding portfolio of innovative solutions, Personalis is strat...

GNG Research Analysis

GNG Research scores Personalis Inc (PSNL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PSNL.

Frequently Asked Questions

Does PSNL pay dividends?

Personalis Inc (PSNL) does not currently pay a regular dividend.

What is PSNL's market cap?

Personalis Inc (PSNL) has a market capitalization of $1.18B with a current stock price of $11.14.